Verified July 2026 · Cited to primary sources

Best Peptides for Weight Loss (2026): Ranked by Evidence

Every peptide marketed for fat loss, graded by human evidence and legal status. The honest short answer: no research peptide here beats an approved GLP-1 medication for weight loss — and the one Grade-A option (tesamorelin) is only FDA-approved for a narrow HIV indication.

Strongest human evidence in this category

TesamorelinGrade A

Tesamorelin is the only Grade-A option, but it is approved for HIV-associated visceral fat, not general weight loss. Retatrutide (Grade B) is investigational and not legally available. MOTS-c is Grade D. For proven, legally-accessible weight loss today, the evidence points to approved GLP-1 medications — not a research peptide.

For proven weight loss

GLP-1s are grade-A territory.

No peptide on this page has proven, legally-available weight-loss data that beats an approved GLP-1. Our sister site ranks 52 providers on the medications that actually work — honestly, the same way we grade peptides here.

Compare 52 GLP-1 providers →

How we ranked these

Three criteria, applied the same way to every peptide.

We don't rank by popularity or by what we can sell you. Every peptide below is ordered by the same fixed rubric — affiliate availability never moves a grade.

  1. 1Strength of human evidence — the A–F Evidence Grade. FDA approval and published human RCTs at the top (A); animal-only and failed-in-humans at the bottom (D–F). This is the primary sort key.
  2. 2Legal accessibility — a separate factual badge: FDA-approved, compoundable (503A), under FDA review, research-only, or legal topical cosmetic.
  3. 3Safety profile — a green/amber/red flag for how well-characterized the human safety data is. Documented harms or disproven-but-still-sold earns red.

FDA testing has found roughly 40% of online and compounded peptides carried incorrect dosages or undeclared ingredients — the reason a rubric like this exists. See the full A–F methodology →

The ranking, in order of evidence.

  1. 1. Tesamorelin

    Grade AFDA-approved / proven in humans

    A GHRH analog that stimulates the pituitary to release growth hormone, which reduces visceral (abdominal) fat.

    Tesamorelin is an FDA-approved drug (Egrifta, 2010) — Grade A, the strongest evidence tier here. But it is approved for HIV-associated visceral fat, not general weight loss; for that, approved GLP-1s are the evidence-backed route.

    See the evidence →

  2. 2. Retatrutide

    Grade BReal human trials, limited or historical

    A triple agonist of the GIP, GLP-1 and glucagon receptors that suppresses appetite and raises energy expenditure to drive weight loss.

    Retatrutide is investigational (Phase 3), not FDA-approved, and not legally available. Human evidence is Grade B — strong published Phase 2 weight-loss data, but not a finished approval. For proven weight loss you can access legally today, see our GLP-1 guidance.

    See the evidence →

  3. 3. MOTS-c

    Grade DAnimal studies only, unproven in humans

    Mitochondrial-derived "exercise mimetic" that activates AMPK to improve insulin sensitivity and metabolic homeostasis in preclinical models.

    MOTS-c is not FDA-approved and is under FDA review (July 23, 2026 PCAC). Human evidence is Grade D — metabolic effects are mostly preclinical, with human data limited to associations. For actual weight loss, an approved GLP-1 is the evidence-backed route.

    See the evidence →

Weight Loss: 3 peptides, ranked by evidence.

Peptides marketed for weight loss, ranked by strength of human evidence, with legal status and typical cost.
PeptideEvidence
Tesamorelin

One of only two FDA-approved peptides in this space — proven to cut visceral fat, but approved for a narrow HIV indication.

Grade A

FDA-approved / proven in humans

See the evidence →
Retatrutide

The next-generation weight-loss peptide with the strongest efficacy signal — but it is investigational and not yet available by any legal route.

Grade B

Real human trials, limited or historical

See the evidence →
MOTS-c

An "exercise-mimetic" metabolic peptide — real mechanistic interest, but human evidence is association-only.

Grade D

Animal studies only, unproven in humans

See the evidence →

Reading this table: Evidence is the A–F human-proof grade; Legal status and Safety are separate factual badges; Verdict is our honest one-line take. Affiliate availability never changes a grade. Full methodology.

FAQ

Best peptides for Weight Loss: FAQ

What is the best peptide for weight loss?

Honestly, none of the research peptides beat an approved GLP-1 medication. Tesamorelin is the only Grade-A option here, but it is FDA-approved for HIV-associated visceral fat, not general weight loss. Retatrutide (Grade B) is investigational and not legally available, and MOTS-c is Grade D — animal data only.

Does MOTS-c cause weight loss?

MOTS-c improves metabolism and insulin sensitivity in animal models and is marketed as an "exercise mimetic," but human evidence is association-only — Grade D. No controlled human trial shows it produces weight loss.

Is any weight-loss peptide FDA-approved?

Among the peptides here, only tesamorelin is FDA-approved, and only to reduce excess visceral abdominal fat in HIV-associated lipodystrophy — not for general weight loss. Retatrutide is still in Phase 3 trials and not approved.

Read the evidence

Before you buy anything

Other goals

The monthly peptide evidence brief.

What the research and the FDA actually say — one short email a month. Unsubscribe anytime.

No spam. We never sell your email. Editorial policy.